Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 2.7T | 3.7T | 2.7T | 3.6T |
Cost of revenue | 1.0T | 1.5T | 993.3B | 1.4T |
Gross profit | 1.7T | 2.2T | 1.7T | 2.2T |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 526.3B | 635.0B | 595.4B | 465.4B |
Other operating expenses | 88.8B | 623.5B | 129.5B | 72.9B |
Operating income | 684.9B | 421.5B | 725.7B | 1.4T |
Non operating interest income | ||||
Income | 85.8B | 89.9B | 107.2B | 119.2B |
Expense | 383.3B | 378.9B | 367.8B | 323.4B |
Other income expense | — | — | — | — |
Pretax income | 347.4B | 1.8T | 472.3B | 1.1T |
Tax provision | 2.7B | 4.8B | 3.4B | 17.9B |
Net income | 344.7B | 1.8T | 468.9B | 1.1T |
Basic EPS | 15.3 | — | — | — |
Diluted EPS | 15.3 | — | — | — |
Basic average shares | 20.9B | — | — | — |
Diluted average shares | 20.9B | — | — | — |
EBITDA | 744.8B | 632.4B | 858.8B | 1.4T |
Net income from continuing op. | — | — | — | — |
Minority interests | -24.1B | -147.5B | -100.1B | -207.7B |
Preferred stock dividends | 0 | 0 | 0 | 0 |